cbdMD (YCBD) Return on Capital Employed (2017 - 2025)

cbdMD has disclosed Return on Capital Employed across 9 years of filings, most recently posting 28.37% for Q4 2025.

• Return on Capital Employed for Q4 2025 came in at 28.37%, up 9506.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 28.37% (up 9506.0% YoY), and the FY2025 annual result was 29.6%, up 3990.0% from the prior year.
• Return on Capital Employed came in at 28.37% for Q4 2025 at cbdMD, up from 31.05% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 10.2% in Q1 2021 to a low of 287.32% in Q2 2024.
• The 5-year median for Return on Capital Employed is 92.54% (2024), against an average of 104.41%.
• Across the five-year window, Return on Capital Employed sank 21043 bps in 2024 and surged 26107 bps in 2025, its largest moves.
• cbdMD's Return on Capital Employed stood at 40.82% in 2021, then tumbled by 328 bps to 174.78% in 2022, then dropped by 15 bps to 201.66% in 2023, then surged by 39 bps to 123.43% in 2024, then soared by 77 bps to 28.37% in 2025.
• The last three Return on Capital Employed figures came in at 28.37% (Q4 2025), 31.05% (Q3 2025), and 26.25% (Q2 2025), per Business Quant data.